Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Frontiers Media SA
2017
|
| Series: | Frontiers Research Topics
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_61823 | ||
| 005 | 20210212 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20210212s2017 xx |||||o ||| 0|eng d | ||
| 020 | |a 978-2-88945-327-6 | ||
| 020 | |a 9782889453276 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3389/978-2-88945-327-6 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a PSG |2 bicssc | |
| 100 | 1 | |a Carlos P. Taborda |4 auth | |
| 700 | 1 | |a Joshua D. Nosanchuk |4 auth | |
| 245 | 1 | 0 | |a Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier |
| 260 | |b Frontiers Media SA |c 2017 | ||
| 300 | |a 1 electronic resource (183 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Frontiers Research Topics | |
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from certain compromised hosts. Additionally, invasive fungal diseases continue to have unacceptably high mortality rates. A growing body of work has focused on the utility of vaccines and/or immunotherapy as a powerful tool in combating mycoses, either for the active treatment, as an adjuvant, or in the prevention of specific fungal pathogens. Also, it is growing the interest over new drugs development as second choice for treatment when traditional chemotherapy fail. This Research Topic will detail the exciting progress in developing vaccines, immunotherapy and new drugs for fungi. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Microbiology (non-medical) |2 bicssc | |
| 653 | |a antifugal drugs | ||
| 653 | |a vaccine | ||
| 653 | |a peptide | ||
| 653 | |a antibody | ||
| 653 | |a virulence | ||
| 653 | |a fungi | ||
| 653 | |a immunotherapy | ||
| 653 | |a humanized antibody | ||
| 653 | |a mycosis | ||
| 653 | |a cell biology | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://www.frontiersin.org/research-topics/4726/vaccines-immunotherapy-and-new-antifungal-therapy-against-fungi-updates-in-the-new-frontier |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/61823 |7 0 |z DOAB: description of the publication |